The GLP-1 Database
Comprehensive, evidence-based profiles for every FDA-approved weight loss medication.
Ozempic
(semaglutide)
Approved for: Weight Loss & Type 2 Diabetes
Ozempic is a once-weekly injectable GLP-1 receptor agonist approved for type 2 diabetes, widely used off-label for weigh…
Novo Nordisk
View Full ProfileWegovy
(semaglutide)
Approved for: Weight Loss
Wegovy is a higher-dose semaglutide injection specifically approved for chronic weight management in adults with obesity…
Novo Nordisk
View Full ProfileMounjaro
(tirzepatide)
Approved for: Weight Loss & Type 2 Diabetes
Mounjaro is a once-weekly dual GIP/GLP-1 receptor agonist approved for type 2 diabetes, with significant weight loss eff…
Eli Lilly
View Full ProfileZepbound
(tirzepatide)
Approved for: Weight Loss
Zepbound is a tirzepatide injection specifically approved for chronic weight management, offering the same dual-action m…
Eli Lilly
View Full ProfileSaxenda
(liraglutide)
Approved for: Weight Loss
Saxenda is a daily injectable GLP-1 receptor agonist approved for chronic weight management, an earlier-generation alter…
Novo Nordisk
View Full ProfileContrave
(naltrexone-bupropion)
Approved for: Weight Loss
Contrave is an oral combination of naltrexone and bupropion approved for chronic weight management, targeting appetite a…
Currax Pharmaceuticals
View Full ProfileMedical Disclaimer
Weight Index provides independent, evidence-based information for educational purposes only. This site does not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting, changing, or stopping any medication.